Pages that link to "Q2711291"
Jump to navigation
Jump to search
The following pages link to familial hypercholesterolemia (Q2711291):
Displayed 50 items.
- rosuvastatin (Q415159) (← links)
- ezetimibe (Q417997) (← links)
- colesevelam (Q899036) (← links)
- PCSK9 (Q3359612) (← links)
- (Q10295757) (redirect page) (← links)
- LDLR (Q14872724) (← links)
- APOB (Q14890615) (← links)
- homozygous familial hypercholesterolemia (Q15815863) (← links)
- Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia (Q21093276) (← links)
- Usefulness of lipid apheresis in the treatment of familial hypercholesterolemia (Q21284511) (← links)
- Statins for children with familial hypercholesterolemia (Q24194816) (← links)
- Statins for children with familial hypercholesterolemia (Q24234081) (← links)
- Statins for children with familial hypercholesterolemia (Q24243675) (← links)
- The LDL receptor locus in familial hypercholesterolemia: Multiple mutations disrupt transport and processing of a membrane receptor (Q24301258) (← links)
- Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol (Q24562932) (← links)
- Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity (Q24621801) (← links)
- Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia (Q24797382) (← links)
- Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland (Q26740377) (← links)
- Cardiovascular risk stratification in familial hypercholesterolaemia (Q26749104) (← links)
- The genetics and screening of familial hypercholesterolaemia (Q26753081) (← links)
- Familial hypercholesterolemia: Review of diagnosis, screening, and treatment (Q26770143) (← links)
- Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia (Q26787050) (← links)
- Optimizing Treatment of Familial Hypercholesterolemia in Children and Adolescents (Q26798119) (← links)
- Cascade Screening in Familial Hypercholesterolemia: Advancing Forward (Q26801558) (← links)
- The inheritance of familial hypercholesterolemia (Q26810089) (← links)
- Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice (Q26828401) (← links)
- Familial hypercholesterolemia: present and future management (Q26828489) (← links)
- Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia (Q26828780) (← links)
- Heterozygous familial hypercholesterolemia (Q26851567) (← links)
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society (Q27024882) (← links)
- Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population (Q27025178) (← links)
- Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair (Q27632019) (← links)
- Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia (Q27644461) (← links)
- Structural and biochemical characterization of the wild type PCSK9-EGF(AB) complex and natural familial hypercholesterolemia mutants (Q27652867) (← links)
- Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force (Q28068590) (← links)
- Analysis of a recycling-impaired mutant of low density lipoprotein receptor in familial hypercholesterolemia (Q28115121) (← links)
- Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass (Q28142208) (← links)
- A novel soluble chimera for the treatment of familial hypercholesterolemia (Q28144523) (← links)
- Molecular genetics of the LDL receptor gene in familial hypercholesterolemia (Q28207758) (← links)
- Mutation in the ARH gene and a chromosome 13q locus influence cholesterol levels in a new form of digenic-recessive familial hypercholesterolemia (Q28218077) (← links)
- 5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia (Q28241048) (← links)
- Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia (Q28249172) (← links)
- Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study (Q28254501) (← links)
- Screening and treatment of familial hypercholesterolemia - Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014) (Q28264133) (← links)
- Familial hypercholesterolemia in children (Q28271081) (← links)
- Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia (Q28272008) (← links)
- Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial (Q28273112) (← links)
- Simvastatin with or without ezetimibe in familial hypercholesterolemia (Q28274454) (← links)
- Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia (Q28282776) (← links)
- Development of coronary heart disease in familial hypercholesterolemia (Q28284322) (← links)